LCM
UTHR icon

Laurion Capital Management’s United Therapeutics UTHR Stock Holding History

Laurion Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-670
Closed -$326K – 502
2025
Q4 		$326K Buy
+670
New +$312K 0.01% 274
2024
Q3 		– Sell
-854
Closed -$272K – 597
2024
Q2 		$272K Buy
+854
New +$226K ﹤0.01% 445
2020
Q3 		– Sell
-2,142
Closed -$259K – 1170
2020
Q2 		$259K Buy
+2,142
New +$241K ﹤0.01% 747
2020
Q1 		– Sell
-20,100
Closed -$1.77M – 1104
2019
Q4 		$1.77M Buy
+20,100
New +$1.77M 0.01% 481
2018
Q3 		– Sell
-3,332
Closed -$377K – 1550
2018
Q2 		$377K Buy
3,332
+1,540
+86% +$169K ﹤0.01% 1032
2018
Q1 		$201K Sell
1,792
-11,200
-86% -$1.42M ﹤0.01% 1231
2017
Q4 		$1.92M Buy
12,992
+1,400
+12% +$178K 0.01% 789
2017
Q3 		$1.36M Sell
11,592
-145,151
-93% -$18.5M 0.01% 877
2017
Q2 		$20.3M Buy
156,743
+23,700
+18% +$2.96M 0.11% 176
2017
Q1 		$18M Buy
+133,043
New +$20.2M 0.14% 187
2016
Q4 		– Sell
-6,900
Closed -$815K – 1299
2016
Q3 		$815K Buy
+6,900
New +$829K 0.01% 597

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Laurion Capital Management's UTHR Position: Q1 2026 in Review

Laurion Capital Management sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 670 shares — an estimated $326K sold.

Laurion Capital Management first reported a position in UTHR in Q3 2016 and held it in 11 quarters. The position peaked at $20.3M in Q2 2017. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Laurion Capital Management reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 670 United Therapeutics shares in Q1 2026, an estimated $326K.
  • Laurion Capital Management first reported a position in United Therapeutics in Q3 2016 and held it in 11 quarters.
  • Laurion Capital Management's United Therapeutics position peaked at $20.3M in Q2 2017.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.